Navigation Links
Elekta Sees Record Attendance and Record Number of Submitted Abstracts at International Leksell Gamma Knife(R) Society Meeting in Quebec, Canada
Date:5/21/2008

STOCKHOLM, Sweden, May 21 /PRNewswire/ -- At the 14th International Leksell Gamma Knife(R) Society Meeting on May 18-22, over 500 participants including neurosurgeons, radiation oncologists and other medical specialists using Leksell Gamma Knife for treatment of tumors and other brain disorders convened at the historic Chateau Frontenac Hotel in Quebec, Canada. During the meeting, 260 oral and poster presentations covered treatment of malignant and benign brain tumors, functional neurosurgery, imaging and biology as well as physics and technology. Wednesday, May 21, the prestigious Pioneers in Radiosurgery Award was presented to John Flickinger, M.D., Professor of Radiation Oncology and Neurological Surgery at the University of Pittsburgh for his early pioneering work on prediction of complications following Gamma Knife(R) surgery.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020318/ELEKTALOGO )

The Leksell Gamma Knife Society was established in 1989 to provide a forum for Gamma Knife users to share information, experiences, clinical techniques and advanced scientific research in their quest to non-invasively treat an expanding number of brain disorders. The meetings, which are held biannually, result in a large number of clinical publications, in recent years published as a supplement to Journal of Neurosurgery. The Society plays an important role in increasing the visibility and acceptance of Gamma Knife surgery in the worldwide medical community, among healthcare providers and among patients. The open sharing of results and experiences allows all Gamma Knife users to maintain leadership in the field of intracranial radiosurgery, based on the most recent clinical advancements.

The 14th meeting in Quebec is held with the theme, "Je me Souviens ... " ("I Remember ... "), which is the motto of Quebec. The theme connects the celebration of Quebec 400 year lo
'/>"/>

SOURCE Elekta, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Johns Hopkins to add Elekta Synergy S(R) to Cancer Treatment Lineup
2. Elekta Demonstrates Commitment to Stereotactic Innovation at EANS
3. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
4. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
5. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
6. Elekta Brings Intelligent Ways to Manage Motion During Cancer Treatment to ESTRO
7. Elekta Displays Complete Volumetric Intensity Modulated Arc Therapy Solutions at ESTRO
8. Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007
9. Elekta Announces Elekta Infinity - a New System for Faster and More Precise Treatment of Cancer Tumors
10. Beaumont Hospital, Royal Oak Treats Its First Patients With Elekta Axesse
11. Elekta Showcases Stereotactic Systems for Cancer Care at Astro 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced today that in connection with its previously announced unit offering
(Date:12/2/2009)JERUSALEM, Israel, December 2 Gamida Cell announced today,a feasibility study evaluating the preclinical (animal study) safety and,efficacy of a gene therapy product which combines technology from We
(Date:12/2/2009)QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today annou
(Date:12/1/2009)Dr. Kerry Solomon announced that he has joined Carolina Eyecare Physicians and has launched his redesigned website at www.DrKerrySolomon.com , which was developed by Medical Consulting Group. Dr. So
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6
...I and Endovascular Forum Launch Interactive, Case-...ide Learning and Collaboration , , LAS VEGAS, May...e complication, another physician has likely seen ...iovascular Angiography and Interventions (SCAI) an...es Company, today unveiled a new educational Websi...
...TTLE, May 6 Dendreon Corporation (Nasdaq: DNDN ...ed March 31, 2009. Revenue for the first quarter ...arter ended March 31, 2008. , , Dendreon,s tota...rch 31, 2009 were $17.0 million compared to $19.2 ... for the quarter ended March 31, 2009 was $15.4 mi...
...MBRIDGE, Mass. May 5, 2009 Researchers at the Ha...SEAS), in collaboration with researchers from Worc...ed, for the first time, that the activation energy...ted by the surrounding dielectric and can be modif.... , The finding, published in the April 6 issue o...
Other Biology Technology:New Website Connects Physicians to Solve Challenging Cases and Share Experiences 2New Website Connects Physicians to Solve Challenging Cases and Share Experiences 3New Website Connects Physicians to Solve Challenging Cases and Share Experiences 4Dendreon Reports First Quarter 2009 Financial Results 2Dendreon Reports First Quarter 2009 Financial Results 3Dendreon Reports First Quarter 2009 Financial Results 4Dendreon Reports First Quarter 2009 Financial Results 5Scientists demonstrate effect of confining dielectrics on semiconductor nanowire conductivity 2
(Date:12/3/2009)Have you ever felt overly upset by a social snubbing? Your genetics, not your friends, may be at fault. , Scientists have long known that opium-like painkillers, called opioids, relieve not only phys
(Date:12/3/2009)The 30-year record low in Antarctic snowmelt that occurred during the 2008-09 austral summer was likely due to concurrent strong positive phases for two main climate drivers, ENSO (El Nio - Southern O
(Date:12/2/2009)PHILADELPHIA People who smoke their first cigarette within minutes after waking up have much higher levels of cotinine, a by-product of nicotine when processed by the body, than those who wait to smo
Breaking Biology News(10 mins):CCNY professor foresees rising Antarctic snowmelt 2Increased nicotine levels detected in those who light-up earlier 2Data from Jazz Pharmaceuticals First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences 5493 1Data from Jazz Pharmaceuticals First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences 5493 2Data from Jazz Pharmaceuticals First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences 5493 3New 2009 Cumulative Supplement to Pharmaceutical Patent Law Examines Critical Intersection Of Patent Law and Food And Drug Law 59490 1New 2009 Cumulative Supplement to Pharmaceutical Patent Law Examines Critical Intersection Of Patent Law and Food And Drug Law 59490 2New 2009 Cumulative Supplement to Pharmaceutical Patent Law Examines Critical Intersection Of Patent Law and Food And Drug Law 59490 3American Academy of Physician Assistants Applauds Senate Finance Committee for Advancing Health Reform Legislation 59488 1American Academy of Physician Assistants Applauds Senate Finance Committee for Advancing Health Reform Legislation 59488 2
...dence suggesting an alternative form of natural vi...lood in humans at levels determined to protect aga...rs naturally in eight different forms. The primary...ol, or TCP. But another natural form of vitamin E ...eated Ohio State University Medical Center studies...
...g smoking can improve lung function test scores by... The findings appear in the second issue for July ...itical Care Medicine, published by the American Th...Departments of Respiratory Medicine and Immunology...s studied 11 asthmatics who continued to smoke and...
...hildren under age 6 in Massachusetts over 22 years...n--especially infants--are now more likely to be o...of Ambulatory Care and Prevention of Harvard Medic...ars in the July issue of Obesity. , "The obesity e... children," says Matthew Gillman, MD, senior autho...
Other Biology News:Natural vitamin E tocotrienol reaches blood at protective levels 2Natural vitamin E tocotrienol reaches blood at protective levels 3Quitting smoking improves lung function considerably 2Today's babies are fatter babies 2
pYES2 from Invitrogen
Nunc MicroWell Mini Trays from Invitrogen
Rabbit Anti-Human MTHFD1 Polyclonal Antibody, Unconjugated from Atlas Antibodies
GIBCO Improved MEM Zn++ Option (Richter's Modification) liquid from Invitrogen
Biology Products: